Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Yin Yang 1 (YY1) Acting Primarily As an Oncogene and Rarely As a Tumor Suppressor in Distinct Hematological Malignancies: Prognostic and Therapeutic Implications

Samantha Kaufhold, Stephanie Wottrich, Hermes Garban, MD PhD, Massimo Libra, MD Ph.D., Benjamin Bonavida, PhD

Blood (2016) 128 (22): 5122.

https://doi.org/10.1182/blood.V128.22.5122.5122

Published: 2016

Journal Articles

Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Signaling and p53 Pathways on Apoptosis, Drug Resistance and Therapeutic Sensitivity of Early Hematopoietic Precursor Cells

Stephen Lee Abrams, Linda S Steelman, BS., MS, Melissa L Skolosky, BS, Giovanni Ligresti, PhD, Massimo Libra, MD., James A McCubrey, PhD

Blood (2008) 112 (11): 503.

https://doi.org/10.1182/blood.V112.11.503.503

Published: 2008

Journal Articles

Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Pathways in Prevention of Apoptosis and Induction of Drug Resistance in Myeloid Hematopoietic Cells.

Steve L. Abrams, BS, Camilla Evangelisti, PhD, Francesca Chiarini, BS, Negin Misaghian, BS, Jorg Basecke, MD, Michele Millela, MD, Agostino Tafuri, MD, Massimo Libra, MD, Franca Stivala, MD, Marina Konopleva, MD, Michael Andreeff, MD, Linda S. Steelman, MS, Jacob Troppmair, PhD, Alberto M. Martelli, MD, James A. McCubrey, PhD

Blood (2007) 110 (11): 641.

https://doi.org/10.1182/blood.V110.11.641.641

Published: 2007

Journal Articles

Dominant Role of Raf/MEK/ERK Signaling in Hematopoietic Cell Cycle Progression, Prevention of Apoptosis and Drug Resistance.

James A. McCubrey, PhD, Steven L. Abrams, BS, Linda S. Steelman, MS, Ellis W.T. Wong, BS, William H. Chappell, MS, Jorg Basecke, MD, Franca Stivala, MD, Massimo Libra, MD, PhD, Michele Milella, MD, Agostino Tafuri, MD, Jacob Troppmair, PhD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Camilla Evangelisti, BS, Alberto M. Martelli, MD, PhD

Blood (2006) 108 (11): 1116.

https://doi.org/10.1182/blood.V108.11.1116.1116

Published: 2006

Journal Articles

Role of BRAF Mutations in Hematopoietic Malignancies and the Induction of Cytokine-Independence-Synergy with PI3K/Akt Pathway.

Massimo Libra, MD, Maria C. Mazzarino, MD, Valli De Re, PhD, Linda S. Steelman, MS, Steven L. Abrams, BS, Fred E. Bertrand, PhD, John G. Shelton, PhD, Sarah Molton, PhD, Martin McMahon, PhD, James A. McCubrey, PhD

Blood (2005) 106 (11): 4291.

https://doi.org/10.1182/blood.V106.11.4291.4291

Published: 2005

NARROW

Yin Yang 1 (YY1) Acting Primarily As an Oncogene and Rarely As a Tumor Suppressor in Distinct Hematological Malignancies: Prognostic and Therapeutic Implications

Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Signaling and p53 Pathways on Apoptosis, Drug Resistance and Therapeutic Sensitivity of Early Hematopoietic Precursor Cells

Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Pathways in Prevention of Apoptosis and Induction of Drug Resistance in Myeloid Hematopoietic Cells.

Dominant Role of Raf/MEK/ERK Signaling in Hematopoietic Cell Cycle Progression, Prevention of Apoptosis and Drug Resistance.

Role of BRAF Mutations in Hematopoietic Malignancies and the Induction of Cytokine-Independence-Synergy with PI3K/Akt Pathway.

Email alerts

ASH Publications

American Society of Hematology

Yin Yang 1 (YY1) Acting Primarily As an Oncogene and Rarely As a Tumor Suppressor in Distinct Hematological Malignancies: Prognostic and Therapeutic Implications

Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Signaling and p53 Pathways on Apoptosis, Drug Resistance and Therapeutic Sensitivity of Early Hematopoietic Precursor Cells

Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Pathways in Prevention of Apoptosis and Induction of Drug Resistance in Myeloid Hematopoietic Cells.

Dominant Role of Raf/MEK/ERK Signaling in Hematopoietic Cell Cycle Progression, Prevention of Apoptosis and Drug Resistance.

Role of BRAF Mutations in Hematopoietic Malignancies and the Induction of Cytokine-Independence-Synergy with PI3K/Akt Pathway.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only